Your browser doesn't support javascript.
loading
A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors.
Xue, Diyuan; Moon, Benjamin; Liao, Jing; Guo, Jingya; Zou, Zhuangzhi; Han, Yanfei; Cao, Shuaishuai; Wang, Yang; Fu, Yang-Xin; Peng, Hua.
Afiliación
  • Xue D; Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
  • Moon B; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Liao J; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA.
  • Guo J; Guangdong Institute of Gastroenterology, Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China.
  • Zou Z; Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
  • Han Y; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Cao S; Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
  • Wang Y; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Fu YX; Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
  • Peng H; University of Chinese Academy of Sciences, Beijing 100049, China.
Sci Immunol ; 7(67): eabi6899, 2022 Jan 07.
Article en En | MEDLINE | ID: mdl-34995098
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T Citotóxicos / Interleucina-12 / Neoplasias Límite: Animals Idioma: En Revista: Sci Immunol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T Citotóxicos / Interleucina-12 / Neoplasias Límite: Animals Idioma: En Revista: Sci Immunol Año: 2022 Tipo del documento: Article País de afiliación: China